STOCK INFORMATION Advicenne shares were listed on Euronext Paris on December 6, 2017 and on Euronext Brussels on June 12, 2019. ISIN code: FR0013296746 Ticker: ADVIC Number of outstanding shares: 8 062 344 Eligible for PEA and PEA-PME CLICK HERE FOR LIVE STOCK PRICE OWNERSHIP STRUCTURE ON JANUARY 5, 2018 Your privacy is important to us We use cookies for our website advicenne.com to ensure it functions correctly, improve its performance and features, measure its audience/traffic and remember your browser preferences. You can configure and deactivate cookies by clicking on « Manage cookies ». Your preferences will be saved for 12 months. You can change your decision and modify your choices at any time by clicking « Manage cookies » at the bottom of each page or by going to our « Cookies policy » by clicking the link at the bottom of each page.

CORPORATE PROFILE Advicenne is a specialty pharmaceutical company dedicated to developing and commercializing innovative treatments for those suffering from rare kidney disease. Our lead drug candidate is currently in late-stage clinical trials for two indications. In 2017, ADV7103 was granted orphan drug designation by the European Commission in the treatment of distal renal tubular acidosis (dRTA), a rare kidney disorder that occurs when the kidneys are unable to effectively remove the buildup of circulating acids in the blood. READ MORE STOCK QUOTE ADVIC (Euronext Paris – Brussels) CLICK HERE FOR LIVE STOCK PRICE PRESS RELEASES VIEW ALL Advicenne Reports 2021 Half Year Financial Results Advicenne Receives MHRA Approval to Market Sibnayal™ (ADV7103) in the UK for the Treatment of dRTA Advicenne successfully raises circa €9.4m in a placement reserved to a category of persons UPCOMING EVENTS No event found! FINANCIAL REPORTS Financial Annual Report 2019 Financial Statements IFRS 2019 Interim financial report – June 2019 VIEW ALL Your privacy is important to us We use cookies for our website advicenne.com to ensure it functions correctly, improve its performance and features, measure its audience/traffic and remember your browser preferences. You can configure and deactivate cookies by clicking on « Manage cookies ». Your preferences will be saved for 12 months. You can change your decision and modify your choices at any time by clicking « Manage cookies » at the bottom of each page or by going to our « Cookies policy » by clicking the link at the bottom of each page. Accept all and access websiteManage cookiesReject all and access website